Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
University of California San Francisco, San Francisco, California University of Colorado - Anschutz Medical Campus, Aurora, Colorado Johns Hopkins University, Baltimore, Maryland Brigham and Women's Hospital, Boston, Massachusetts Mayo Clinic, Rochester, Minnesota NYU Langone Health, New York, New York Cleveland Clinic, Cleveland, Ohio